Notch receptor-ligand binding and activation: Insights from molecular studies

Seminars in Cell and Developmental Biology

Volumn 23, Issue 4, 2012, Pages 421-428

  Chillakuri, Chandramouli R ^a   Sheppard, Devon ^b   Lea, Susan M ^b   Handford, Penny A ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Cis trans; Epidermal growth factor like; Jagged; Notch; Notch signalling

Indexed keywords

ANKYRIN; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; JAGGED1; NOTCH RECEPTOR; NOTCH1 RECEPTOR;

CELL AGGREGATION; CELL COMMUNICATION; CELL SURFACE; CRYSTAL STRUCTURE; CRYSTALLIZATION; DROSOPHILA; ENZYME ACTIVATION; EXON; HUMAN; IN VITRO STUDY; IN VIVO STUDY; LIGAND BINDING; MOLECULAR DOCKING; NONHUMAN; PROTEIN CLEAVAGE; PROTEIN DEGRADATION; PROTEIN INTERACTION; PROTEIN STRUCTURE; REVIEW; RNA INTERFERENCE; SIGNAL TRANSDUCTION;

METAZOA;

EID: 84861995097     PISSN: 10849521     EISSN: 10963634     Source Type: Journal    
DOI: 10.1016/j.semcdb.2012.01.009     Document Type: Review

References (50)

1. Kopan R., Ilagan M.X. The canonical Notch signalling pathway: unfolding the activation mechanism. Cell 2009, 137:216-233.
2. Sanchez-Irizarry C., Carpenter A.C., Weng A.P., Pear W.S., Aster J.C., Blacklow S.C. Notch subunit heterodimerization and prevention of ligand-independent proteolytic activation depend, respectively on a novel domain and the LNR repeats. Mol Cell Biol 2004, 24:9265-9273.
3. Tamura K., Taniguchi Y., Minoguchi S., Sakai T., Tun T., Furukawa T., et al. Physical interaction between a novel domain of the receptor Notch and the transcription factor RBO-J kappa/Su(H). Curr Biol 1995, 5:1416-1423.
4. Weng A.P., Ferrando A.A., Lee W., Morris J.P., Silverman L.B., Sanchez-Irizarry C., et al. Activating mutations of Notch1 in human T cell acute lymphoblastic leukemia. Science 2004, 306:269-271.
5. Rebay I., Flemming R.J., Fehon R.G., Cherbas L., Cherbas P., Artavanis-Tsakonas S. Specific EGF repeats of Notch mediate interactions with Delta and Serrate: implications for Notch as a multifunctional receptor. Cell 1991, 67:687-699.
6. Rebay I., Fehon R.G., Artavanis-Tsakonas S. Specific truncations of Drosophila Notch define dominant activated and dominant negative forms of the receptor. Cell 1993, 74:319-329.
7. Downing A.K., Knott V., Werner J.M., Cardy C.M., Campbell I.D., Handford P.A. Solution structure of a pair of calcium-binding epidermal growth factor-like domains: implications for the Marfan syndrome and other genetic disorders. Cell 1996, 85:597-605.
8. Smallridge R.S., Whiteman P., Doering K., Handford P.A., Downing A.K. EGF-like domain calcium affinity modulated by N-terminal domain linkage in human fibrillin-1. J Mol Biol 2003, 286:661-668.
9. Hambleton S., Valeyev N.V., Muranyi A., Knott V., Werner J.M., McMichael A.J., et al. Structural and functional properties of the human Notch-1 ligand binding region. Structure 2004, 12:2173-2183.
10. Cordle J., Redfield C., Stacey M., van der Merwe P.A., Willis A.C., Champion B.R., et al. Localization of the delta-like-1-binding site in human Notch-1 and its modulation by calcium affinity. J Biol Chem 2008, 283:11785-11793.
11. Cordle J., Johnson S., Tay J.Z., Roversi P., Wilkin M.B., de Madrid B.H., et al. A conserved face of the Jagged/Serrate DSL domain is involved in Notch trans-activation and cis-inhibition. Nat Struct Mol Biol 2008, 15:849-857.
12. Okajima T., Xu A., Irvine K.D. Modulation of notch-ligand binding by protein O-fucosyltransferase 1 and fringe. J Biol Chem 2003, 278:42340-42345.
13. Lei L., Xu A., Panin V.M., Irvine K.D. An O-fucose site in the ligand binding domain inhibits Notch activation. Development 2003, 130:6411-6421.
14. Ge C., Stanley P. The O-fucose glycan in the ligand-binding domain of Notch1 regulates embryogenesis and T-cell development. Proc Natl Acad Sci USA 2008, 105:1539-1544.
15. Hiruma-Shimizu K., Hosoguchi K., Liu Y., Fujitani N., Ohta T., Hinou H., et al. Chemical synthesis, folding and structural insights into o-fucosylated epidermal growth factor-like repeat 12 of mouse Notch-1 receptor. J Am Chem Soc 2010, 132:14857-14865.
16. Gordon W.R., Roy M., Vardar-Ulu D., Garfinkel M., Mansour M.R., Aster J.C., et al. Structure of the Notch-1-negative regulatory region: implications for normal activation and pathogenic signalling in T-ALL. Blood 2009, 113:4381-4390.
17. Gordon W.R., Vardar-Ulu d L'Heureux S., Ashworth T., Malecki M.J., Sanchez-Irizarry C., et al. Effects of S1 cleavage on the structure, surface export and signalling activity of human Notch1 and Notch2. PLoS One 2009, 4:e6613.
18. Vardar D., North C.L., Sanchez-Irizarry C., Aster J.C., Blacklow S.C. Nuclear magnetic resonance structure of a prototype Lin12-Notch repeat module from human Notch1. Biochemistry 2003, 42:7061-7067.
19. Rand M.D., Grimm L.M., Artavanis-Tsakonas S., Patriub V., Blacklow S.C., Sklar J., et al. Calcium depletion dissociates and activates heterodimeric notch receptors. Mol Cell Biol 2000, 20:1825-1835.
20. Malecki M.J., Sanchez-Irizarry C., Mitchell J.L., Histen G., Xu M.L., Aster J.C., et al. Leukemia-associated mutations within the Notch1 heterodimerization domain fall into at least two distinct mechanistic classes. Mol Cell Biol 2006, 26:4642-4651.
21. Gordon W.R., Arnett K.L., Blacklow S.C. The molecular logic of Notch signalling - a structural and biochemical perspective. J Cell Sci 2008, 121:3109-3119.
22. Zweifel M.E., Leahy D.J., Hughson F.M., Barrick D. Structure and stability of the ankyrin domain of the Drosophila Notch receptor. Protein Sci 2003, 12:2622-2632.
23. Lubman O.Y., Ilagan M.X., Kopan R., Barrick D. Quantitative dissection of the Notch:CSL interaction:insights into the Notch mediated transcriptional switch. J Mol Biol 2007, 365:577-589.
24. Nam Y., Sliz P., Song L., Aster J.C., Blacklow S.C. Structural basis for co-operativity in recruitment of MAML coactivators to notch transcription complexes. Cell 2006, 124:973-983.
25. Arnett K.L., Hass M., McArthur D.G., Ilagan M.X., Aster J.C., Kopan R., et al. Structural and mechanistic insights into cooperative assembly of dimeric Notch transcription complexes. Nat Struct Mol Biol 2010, 17:1312-1317.
26. Morgan W.D., Birdsall B., Frenkiel T.A., Gradwell M.G., Burghaus P.A., Syed S.H.E., et al. Solution structure of an EGF module pair from the plasmodium falciparum merozite surface protein 1. J Mol Biol 1999, 289:113-122.
27. Xu A., Lei L., Irvine K.D. Regions of Drosophila Notch that contribute to ligand binding and the modulatory influence of Fringe. J Biol Chem 2005, 280:30158-30165.
28. Kelly D.F., Lake R.J., Middlekoop T.C., Fan H.Y., Artavanis-Tsakonas S., Walz T. Molecular structure and dimeric organization of the Notch extracellular domain as revealed by electron microscopy. PLoS 2010, 340:369-380.
29. D'Souza B., Miyamoto A., Weinmaster G. The many facets of Notch ligands. Oncogene 2008, 27:5148-5167.
30. Komatsu H., Chao M.Y., Larkins-Ford J., Corkins M.E., Somers G.A., Tucey T., et al. OSM-11 facilitates LIN-12 Notch signalling during Caenorhabditis elegans vulval development. PLoS Biol 2008, 6:e196.
31. Mizuhara E., Nakatani T., Minaki Y., Sakamoto Y., Ono Y., Takai Y. MAGI1 recruits Dll1 to cadherin-based adherens junctions and stabilizes it on the cell surface. J Biol Chem 2005, 280:26499-26507.
32. Lissemore J.L., Starmer W.T. Phylogenetic analysis of vertebrate and invertebrate Delta/Serrate/LAG-2 (DSL) proteins. Mol Phylogenet Evol 1999, 11:308-319.
33. Pintar A., Guarnaccia C., Dhir S., Pongor S. Exon 6 of human JAG1 encodes a conserved structural unit. BMC Struct Biol 2009, 9:43.
34. de Celis J.F., Bray S.J. Feed-back mechanisms affecting Notch activation at the dorsoventral boundary in the Drosophila wing. Development 1997, 124:3241-3251.
35. Micchelli C.A., Rulifson E.J., Blair S.S. The function and regulation of cut expression on the wing margin of Drosophila: Notch, wingless and a dominant negative role for Delta and Serrate. Development 1997, 124:1485-1495.
36. de Celis J.F., Bray S.J. The Abruptex domain of Notch regulates negative interactions between Notch, its ligands and Fringe. Development 2000, 127:1291-1302.
37. Becam I., Fiuza U.M., Arias A.M., Milán M. A role of receptor Notch in ligand cis-inhibition in Drosophila. Curr Biol 2010, 20:554-560.
38. Shimizu K., Chiba S., Kumano K., Hosoya N., Tkahashi T., Kanda Y., et al. Mouse Jagged1 physically interacts with Notch1 and other Notch receptors. Assessment by quantitative methods. J Biol Chem 1999, 274:32961-32969.
39. Shimizu K., Chiba S., Saito T., Kumano K., Hirai H. Physical interaction of Delta1, Jagged1 and Jagged2 with Notch1 and Notch3 receptors. Biochem Biophys Res Commun 2000, 276:385-389.
40. Pei Z., Baker N.E. Competition between Delta and the Abruptex domain of Notch. BMC Dev Biol 2008, 8:4.
41. Parks A.L., Klueg K.M., Stout J.R., Muskavitch M.A. Ligand endocytosis drives receptor dissociation and activation in the Notch pathway. Development 2000, 127:1373-1378.
42. Ahimou F., Mok L.P., Bardot B., Wesley C. The adhesion force of Notch with Delta and the rate of Notch signalling. J Cell Biol 2004, 167:1217-1229.
43. Harper J.A., Yuan J.S., Tan J.B., Visan I., Guidos C.J. Notch signalling in development and disease. Clin Genet 2003, 64:461-472.
44. Noguera-Troise I., Daly C., Papadopoulos N.J., Coetzee S., Boland P., Gale N.W., et al. Blockade of Dll4 inhibits tumour growth by promoting non-productive angiogenesis. Nature 2006, 444:1032-1037.
45. Yan M., Callahan C.A., Beyer J.C., Allamneni K.P., Zhang G., Ridgway J.B., et al. Chronic Dll4 blockade induces vascular neoplasms. Nature 2010, 463:E6-E7.
46. Yin L., Velazquez O.C., Liu Z.J. Notch signalling: emerging molecular targets for cancer therapy. Biochem Pharmacol 2010, 80:690-701.
47. Dikic I., Schimidt M.H. Notch: implications of endogenous inhibitors for therapy. Bioessays 2010, 32:481-487.
48. Aste-Amézaga M., Zhang N., Lineberger J.E., Arnold B.A., Toner T.J., Gu M., et al. Characterization of Notch1 antibodies that inhibit signalling of both normal and mutated Notch1 receptors. PLoS One 2010, 5:e9094.
49. Wu Y., Cain-Hom C., Choy L., Hagenbeek T.J., de Leon G.P., Chen Y., et al. Therapeutic antibody targeting of individual Notch receptors. Nature 2010, 464:1052-1057.
50. LaVoie Selkoe D.J. The Notch ligands, Jagged and Delta are sequentially processed by alpha-secretase and presenilin/gamma-secretase and release signalling fragments. J Biol Chem 2003, 278:34427-34437.